A Cell Type Selective YM155 Prodrug Targets Receptor-Interacting Protein Kinase 2 to Induce Brain Cancer Cell Death
Por um escritor misterioso
Descrição
A Cell Type Selective YM155 Prodrug Targets Receptor-Interacting
Parenteral high‑dose ascorbate - A possible approach for the
Molecules, Free Full-Text
Microparticles: biogenesis, characteristics and intervention
Nathalia Gazaniga - Graduate Student - The Scripps Research
Kinase drug discovery 20 years after imatinib: progress and future
Small-molecule protein kinase inhibitors and their effects on the
Cells, Free Full-Text
The solute carrier SLC35F2 enables YM155-mediated DNA damage
Cells, Free Full-Text
Journal of the American Chemical Society
Enzymatically Forming Intranuclear Peptide Assemblies for
Mitochondrial DNA-targeted therapy: A novel approach to combat
Frontiers The Androgen Receptor and Its Crosstalk With the Src
PDF) The solute carrier SLC35F2 enables YM155-mediated DNA damage
de
por adulto (o preço varia de acordo com o tamanho do grupo)